Insiders / Bedrosian Camille L

Bedrosian Camille L

CIK 1326969personinsider

Companies

2

First seen

Mar 4, 2026

Last activity

Jun 22, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
Amylyx Pharmaceuticals, Inc. · AMLX	Executive	265,285	265,285	3	—
Crinetics Pharmaceuticals, Inc. · CRNX	Director	22,225	22,225	2	—

All securities held

4 positions · latest reported per filing

Company	Security	Shares	As of
Amylyx Pharmaceuticals, Inc.	Common Stock	265,285	Mar 5, 2026
Amylyx Pharmaceuticals, Inc.	Stock Option (Right to Buy)Derivative	143,985	Mar 5, 2026
Crinetics Pharmaceuticals, Inc.	Common Stock	22,225	Jun 18, 2026
Crinetics Pharmaceuticals, Inc.	Stock Option (Right to Buy)Derivative	9,730	Jun 18, 2026

Activity

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Mar 2, 2026	Sell	AMLX Amylyx Pharmaceuticals, Inc. Common Stock	$94.2K	-6K -3.68%	169,295 0.15% of shares	low
Jun 18, 2026	Grant	CRNX Crinetics Pharmaceuticals, Inc. Common Stock	$0	+6K +36.35%	22,225 0.02% of shares	low
Mar 5, 2026	Grant	AMLX Amylyx Pharmaceuticals, Inc. Common Stock	$0	+96K +56.70%	265,285 0.24% of shares	low
Jun 18, 2026	Grant	CRNX Crinetics Pharmaceuticals, Inc. Stock Option (Right to Buy)	—	+10K	9,730 <0.01% of shares	low
Mar 5, 2026	Grant	AMLX Amylyx Pharmaceuticals, Inc. Stock Option (Right to Buy)	—	+144K	143,985 0.13% of shares	low